There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AmerisourceBergen (ABC – Research Report), Biogen (BIIB – Research Report) and Elevance Health (ELV – Research Report) with bullish sentiments.
AmerisourceBergen (ABC)
Robert W. Baird analyst Eric Coldwell reiterated a Buy rating on AmerisourceBergen yesterday and set a price target of $205.00. The company’s shares closed last Thursday at $165.96.
According to TipRanks.com, Coldwell is a 4-star analyst with an average return of
Currently, the analyst consensus on AmerisourceBergen is a Moderate Buy with an average price target of $183.00, which is an 11.3% upside from current levels. In a report released yesterday, Bank of America Securities also maintained a Buy rating on the stock with a $192.00 price target.
See the top stocks recommended by analysts >>
Biogen (BIIB)
Robert W. Baird analyst Brian Skorney maintained a Buy rating on Biogen yesterday and set a price target of $340.00. The company’s shares closed last Thursday at $290.27.
According to TipRanks.com, Skorney is a 1-star analyst with an average return of
Currently, the analyst consensus on Biogen is a Strong Buy with an average price target of $326.94, which is a 12.6% upside from current levels. In a report issued on April 17, Piper Sandler also upgraded the stock to Buy with a $346.00 price target.
Elevance Health (ELV)
In a report released today, Joseph France from Loop Capital Markets maintained a Buy rating on Elevance Health, with a price target of $550.00. The company’s shares closed last Thursday at $454.93, close to its 52-week low of $440.02.
According to TipRanks.com, France is a 5-star analyst with an average return of
Currently, the analyst consensus on Elevance Health is a Strong Buy with an average price target of $572.93, representing a 25.3% upside. In a report released yesterday, Jefferies also maintained a Buy rating on the stock with a $558.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABC:
